Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/7/2017
SIETES contiene 91904 citas

 
 
 1 a 20 de 268 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Becker WC, Fiellin DA. Abuse-deterrent opioid formulations - Putting the potential benefits into perspective. N Engl J Med 2017;376:2103-5. [Ref.ID 101625]
2. Cita con resumen
Spelsberg A , Prugger C , Doshi P , Ostrowski K , Witte T , Hüsgen D , Keil U , for the Working Group on Health and Working Group on Freedom of Information Transparency International Deutschland eV. Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies. BMJ 2017;356:j337. [Ref.ID 101390]
3. Cita con resumen
Ravnskov U, Diamond DM, Hama R, Hamazaki T, Hammarskjöld B, Hynes N, Kendrick M, Langsjoen PH, Malhotra A, Mascitelli L, McCully KS, Ogushi Y, Okuyama H, Rosch PJ, Schersten T, Sultan S, Sundberg R. Lack of an association or an inverse association between low-density lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ Open 2016:28 de junio. [Ref.ID 100445]
4. Cita con resumen
Garattini S. The European Medicines Agency is still too close to industry. BMJ 2016;353:i2412. [Ref.ID 100360]
5. Cita con resumen
Boussageon R, Gueyffier F, Cornu C. Metformin as firstline treatment for type 2 diabetes: are we sure?. BMJ 2016;352:h6748. [Ref.ID 99967]
6.Enlace a cita originalTiene citas relacionadas Cita con resumen
Marciniak TA, Cherepanov V, Golukhova I, Hyun Kim M, Serebruany V. Drug discontinuation and follow-up rates in oral antithrombotic trials. JAMA Intern Med 2016;176:11 de enero. [Ref.ID 99961]
7.Enlace a cita original Cita con resumen
Anónimo. Cómo vender medicamentos peligrosos: el caso del Trankimazin. NoGracias 2015:27 de agosto. [Ref.ID 99809]
8. Cita con resumen
Naci H, Carter AW, Mossialos E. Why the drug development pipeline is not delivering better medicines. BMJ 2015;351:h5542. [Ref.ID 99639]
9. Cita con resumen
Watson R. Council of Europe tackles drug industry’s “less noble” side. BMJ 2015;351:h5474. [Ref.ID 99593]
11. Cita con resumen
Mozaffarian D, Ludwig DS. The 2015 US dietary guidelines: lifting the ban on total dietary fat. JAMA 2015;313:2421-2. [Ref.ID 99229]
12. Cita con resumen
Gotzsche PC, Young AH, Crace J. Does long term use of psychiatric drugs cause more harm than good?. BMJ 2015;350:h2435. [Ref.ID 99101]
13. Cita con resumen
Scott DL, Ibrahim F, Farewell V, O'Keeffe AG, Walker D, Kelly C, Birrell F, Chakravarty K, Maddison P, Heslin M, Patel A, Kingsley GH. Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial. BMJ 2015;350:h1046. [Ref.ID 98857]
14. Cita con resumen
Husten L. New U.S. guidelines will lift limits on dietary cholesterol. Physician's First Watch 2015:12 de febrero. [Ref.ID 98775]
15.Tiene citas relacionadas Cita con resumen
Trotta F, Da Cas R, Alegiani SS, Gramegna M, Venegoni M, Zocchetti C, Traversa G. Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study. BMJ 2014;348:g3361. [Ref.ID 98028]
16.Tiene citas relacionadas
Fell DB, Dodds L, McNeil S, MacDonald NE. H1N1 influenza vaccination during pregnancy. BMJ 2014;348:g3500. [Ref.ID 98025]
17. Cita con resumen
Spielmans GI, Kirsch I. Drug approval and drug effectiveness. Annual Review of Clinical Psychology 2014;214:741-66. [Ref.ID 97582]
19. Cita con resumen
Hawkes N. Spoof research paper is accepted by 157 open access journals. BMJ 2013;347:5. [Ref.ID 96373]
20. Cita con resumen
Schroll J. Deaths in trial should always be reported. BMJ 2013;347:26. [Ref.ID 96139]
Seleccionar todas
 
 1 a 20 de 268 siguiente >>